EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Pre-clinical Models for Geriatric Pharmacotherapy

Sarah N Hilmer iD, Kristina Johnell iD, John Mach iD

Drugs & Aging · 2024-08 · 41 (8) · 633-640

DOI: 10.1007/s40266-024-01129-6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drugs & Aging, online erschienen am 09.07.2024. Verfasst von Sarah N Hilmer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Kolling Institute, The University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia. sarah.hilmer@sydney.edu.au. Hauptthemen laut MEDLINE: Geriatrics. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

With ageing of the population worldwide and discovery of new medications for prevention and management of age-related conditions, there is increasing use of medications by older adults. There are international efforts to increase the representativeness of participants in clinical trials to match the intended real-world users of the medications across a range of characteristics including age, multimorbidity, polypharmacy and frailty. Currently, much of the data on medication-related harm in older adults are from pharmacovigilance studies. New methods in pre-clinical models have allowed for measurement of exposures (such as chronic exposure, polypharmacy and deprescribing) and outcomes (such as health span functional measures and frailty) that are highly relevant to geriatric pharmacotherapy. Here we describe opportunities for design and implementation of pre-clinical models that can better predict drug effects in geriatric patients. This could improve the translation of new drugs from bench to bedside and improve outcomes of pharmacotherapy in older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GeriatricsHumansAgedAnimalsPolypharmacyDrug Evaluation, PreclinicalAgingDrug Therapy

Autor:innen und Institutionen

  • Kolling Institute, The University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia. sarah.hilmer@sydney.edu.au.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Kolling Institute, The University of Sydney and Northern Sydney Local Health District, St Leonards, NSW, Australia.

ORCID-Profile: Sarah N Hilmer, Kristina Johnell, John Mach

Förderung

  • University of Sydney

Zitieren

APA

Hilmer, S. N., Johnell, K., & Mach, J. (2024). Pre-clinical Models for Geriatric Pharmacotherapy. Drugs & Aging, 41(8), 633-640. https://doi.org/10.1007/s40266-024-01129-6

Vancouver

Hilmer SN, Johnell K, Mach J. Pre-clinical Models for Geriatric Pharmacotherapy. Drugs & Aging. 2024;41(8):633-640. doi:10.1007/s40266-024-01129-6

BibTeX
@article{Hilmer2024,
  author = {Hilmer, Sarah N and Johnell, Kristina and Mach, John},
  title = {Pre-clinical Models for Geriatric Pharmacotherapy},
  journal = {Drugs & Aging},
  year = {2024},
  volume = {41},
  number = {8},
  pages = {633--640},
  doi = {10.1007/s40266-024-01129-6}
}
Kostenlos starten →